HOME >> MEDICINE >> NEWS
Research guides medication choices for young Asthma patients

New research should help physicians choose effective asthma medications tailored to the characteristics of their individual patients. Researchers at National Jewish Medical and Research Center and their colleagues in the National Heart, Lung and Blood Institute's (NHLBI) Childhood Asthma Research and Education Network identify in the February Journal of Allergy and Clinical Immunology specific characteristics in children associated with better responses to inhaled steroids and to leukotriene receptor antagonists. The research builds on a trend to use scientific evidence, rather than trial-and-error, to customize medication choices for specific individuals.

"We found that responses to these two medications varied considerably from child to child," said Stanley Szefler, M.D., lead author and Professor of Pediatrics at National Jewish Medical and Research Center. "Young asthma patients with low pulmonary function or evidence of allergic inflammation are most likely to respond well to inhaled corticosteroids and should try those first. Other young patients can try either the inhaled steroids or leukotriene receptor antagonists first. Patients under 10 years of age who have had asthma for a short time may respond well to the leukotriene receptor antagonists." Inhaled corticosteroids are broadly acting anti-inflammatory medications that are applied directly to the airways by breathing them in.

Leukotriene receptor antagonists, taken in pill form, act systemically to block substances call leukotrienes, which are associated with inflammation and allergic reactions. Both medications are considered effective, but inhaled steroids are currently the preferred long-term therapy for persistent asthma.

"If we can pinpoint in advance which children will do better with a certain type of therapy, we can improve their lives more quickly and save them the risk of trying medications that are less effective for them," noted James Kiley, Ph.D., director of the N
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
1-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... , ... The new strain of Wuhan coronavirus was first identified in China ... and South Korea. The virus is believed to have started in the Chinese city ... , EPA has confirmed that the 2019 novel coronavirus-Wuhan (also 2019-nCoV) has met ...
(Date:1/23/2020)... , ... January 23, 2020 , ... The American Heart ... lives, announced that their Annual Ventura County Go Red for Women Luncheon ... the Four Seasons Westlake Village. Approximately 500 residents are anticipated to attend the premier ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... the state’s life-science industry, presents a panel discussion on gene editing that goes ... ChristianaCare John H. Ammon Medical Education Center, the event will provide an overview ...
(Date:1/23/2020)... ... January 23, 2020 , ... MemoryCare.com , a ... the Best Memory Care Facilities in Pensacola, Florida. The guide identifies 7 memory ... , According to the Alzheimer’s Association , 5.6 million people age 65 ...
(Date:1/23/2020)... , ... January 23, 2020 , ... ... brief demonstrating that in 2019, the Trump Administration dramatically expanded upon discriminatory, ... well-being of LGBTQIA+ people in America and around the world. , “During Donald ...
Breaking Medicine News(10 mins):
(Date:1/23/2020)... ... January 23, 2020 , ... For ... Australian Dream® for effective relief. Now, the company is unveiling new packaging ... sought to develop a new design that better communicates the quality and benefits ...
(Date:1/23/2020)... ... ... Please join American Society of Nuclear Cardiology (ASNC) in congratulating Sharmila Dorbala, MD, ... Dorbala is the director of nuclear cardiology at Brigham and Women’s Hospital, Harvard Medical ... than 20 years as an ASNC member, she has held various officer positions; served ...
(Date:1/23/2020)... ... 2020 , ... EBSCO Information Services (EBSCO), the ... new decision aid within its shared decision making product, Option Grid™ . ... Opioid addiction is a chronic relapsing condition of continued opioid use despite problematic ...
Breaking Medicine Technology:
Cached News: